Dermaclear Pads

Description

Manufactured for DermaQuest®, Inc., located in Hayward, California, this product is produced in the USA. The company’s website is dermaquestinc.com.

Uses and Indications

This drug is indicated for the treatment of acne. There are no teratogenic or nonteratogenic effects associated with its use.

Dosage and Administration

Healthcare professionals are advised to instruct patients to gently rub the pad over any area of the skin that requires treatment. The application should occur every other night or as directed by a qualified skin care professional to ensure optimal results.

To maintain the integrity of the product, it is essential to keep the lid securely closed when not in use to prevent evaporation. Caution should be exercised to avoid overuse, as this may lead to dryness of the skin.

This product is not recommended for individuals with known allergies to aspirin or non-steroidal anti-inflammatory drugs (NSAIDs).

Contraindications

Use is contraindicated in individuals with sensitive skin due to the potential for adverse reactions.

Warnings and Precautions

For external use only. The overuse of this product may lead to dryness of the skin.

It is imperative that this product not be used by individuals with sensitive skin, as it may exacerbate skin conditions or lead to adverse reactions.

Patients should be advised to discontinue use and contact their healthcare provider if severe skin irritation occurs. Additionally, caution is warranted when using this product concurrently with other topical medications, as interactions may lead to increased irritation or reduced efficacy.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients should be aware that this product is intended for external use only. Overuse may lead to dryness of the skin.

In clinical practice, it is advised that patients discontinue use and consult a healthcare professional if severe skin irritation occurs. Additionally, caution is recommended when using this product concurrently with other topical medications, as this may exacerbate adverse reactions.

Drug Interactions

Concurrent use of other topical acne medications may enhance the risk of skin dryness or irritation when used simultaneously or immediately after the application of this product. In such cases, it is advisable to limit the use to one topical medication unless otherwise directed by a healthcare professional.

Additionally, this product is not recommended for individuals with known allergies to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs).

Packaging & NDC

Below are the non-prescription pack sizes of Dermaclear Pads (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely to ensure that the product is kept out of reach, as ingestion may require immediate medical attention or contact with a Poison Control Center.

For application, the product should be gently rubbed over the affected area as needed, typically every other night or as directed by a skin care professional. To prevent dryness, it is important to avoid overuse. The product is not recommended for children with known allergies to aspirin or NSAIDs.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be aware that there is no specific information regarding the use of DERMACLEAR PADS (salicylic acid liquid) during pregnancy. The prescribing information does not indicate whether the product is contraindicated in pregnancy or outline any associated risks to the fetus. Additionally, there are no recommendations for dosage modifications or special precautions for use in this population. Healthcare professionals should consider the lack of data when advising pregnant patients and weigh the potential benefits against any unknown risks.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any considerations related to lactation. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In cases of overdosage, the primary symptom observed is dryness. This may manifest as dryness of the skin, mucous membranes, or other affected areas depending on the route of administration.

Healthcare professionals are advised to monitor patients for signs of excessive dryness and to implement appropriate management strategies. These may include hydration measures, such as the application of moisturizers or the use of humidifiers, to alleviate symptoms.

In the event of significant overdosage, it is recommended that healthcare providers assess the severity of the symptoms and consider supportive care as necessary. If symptoms persist or worsen, further medical evaluation may be warranted to ensure comprehensive management of the patient's condition.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for individuals with sensitive skin. They should be instructed to discontinue use and consult a doctor if they experience severe skin irritation or if they are using other topical medications concurrently.

While using this product, patients should be cautioned to avoid contact with the eyes, lips, and mouth. It is important to inform patients that using other topical acne medications simultaneously or immediately after applying this product may lead to increased dryness or irritation of the skin. In such cases, patients should use only one medication unless otherwise directed by a healthcare professional.

Additionally, patients should be advised to use sunscreen if they are sensitive to the sun or anticipate increased sun exposure while using this product.

Storage and Handling

The product is supplied in a secure container designed to prevent evaporation. It is essential to keep the lid tightly closed when not in use. The recommended usage is every other night or as directed by a skin care professional.

Storage conditions require the product to be kept out of reach of children to ensure safety. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

This product is not suitable for individuals with allergies to aspirin or non-steroidal anti-inflammatory drugs (NSAIDs).

Additional Clinical Information

Patients should gently rub the pad over any area in need, using it every other night or as recommended by their skin care professional. Clinicians should advise patients to avoid contact with the eyes, lips, and mouth. In cases of increased sun exposure or if the patient is sensitive to the sun, the use of sunscreen is recommended. Patients are instructed to discontinue use and consult a doctor if severe skin irritation occurs. Additionally, when using other topical medications concurrently, only one should be applied unless directed otherwise by a healthcare provider.

Drug Information (PDF)

This file contains official product information for Dermaclear Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)